Establishment and amendment of credit facilities

Trivascular Technologies, Inc.
2012 - 2014

Our attorneys represented TriVascular Technologies, Inc., a medical device company, in several venture debt and term loan transactions, including in a recent amendment of its credit facility with CRG (Capital Royalty affiliated funds) providing for US$50 million in borrowings with up to an additional US$15 million available upon achievement of certain revenue milestones.

Email Disclaimer